Prescription drug · ANDA
Lidox 5 Patch (lidocaine 5% patch) NDC 87234-0505
Lidocaine 50 mg/g · Patch · Topical · Injecta Medcial LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87234-0505-3 | 87234050503 | 30 POUCH in 1 PACKAGE (87234-0505-3) / 1 g in 1 POUCH (87234-0505-1)Marketed from May 22, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidox 5 Patch
- Generic name (nonproprietary)
- lidocaine 5% patch
- Active ingredients
- Lidocaine — 50 mg/g
- Dosage form
- Patch
- Route
- Topical
- Labeler
- Injecta Medcial LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209190
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 87234-0505_526b8681-0990-3410-e063-6294a90a79fbSPL ID 526b8681-0990-3410-e063-6294a90a79fbSPL set ID 526b8681-098f-3410-e063-6294a90a79fbRxCUI 1745091UNII 98PI200987
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N487234050503followed by a unit qualifier and the quantityPackage 87234-0505-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209190
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | Asclemed USA, Inc. | 76420-899 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | A-S Medication Solutions | 50090-7857 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | St. Mary's Medical Park Pharmacy | 60760-657 |
| Lidocaine 5% Patchlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | Medcore LLC | 82461-611 |
| Lidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | NuCare Pharmaceuticals,Inc. | 68071-3620 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | REMEDYREPACK INC. | 70518-4487 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | YARAL Pharma Inc. | 82347-0505 |
| Lidocan VIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-900 |
| Lidocan IVlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-910 |
| Lidocanlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | PURETEK CORPORATION | 59088-905 |
| Tridacaine IIIlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-835 |
| Lidocan IIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-907 |
| Tridacaine XLlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-845 |
| Lidocan Vlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-909 |
| Lidocan VIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-911 |